Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural versus systemic ketamine for phantom limb pain
2010-024265-40Phase 3Active
- Sponsor
- Bellvitge University Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in phantom limb pain (PLP) (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Improvement in phantom limb pain at 7 days. Started Mar 2012; status: active.
02
Drugs
ketamine
03
Conditions
phantom limb pain (PLP)
Beyond the preview
Go deeper on 2010-024265-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024265-40.